Meet Xbrane at Börsveckans Digitala Småbolagsdag

Corporate Information




Other Corporate Information

Xbrane Biopharma AB (publ) ("Xbrane" or "the Company”) represented by Martin Åmark, CEO, presents at the Småbolagsdagen February 24, 2021. Follow the presentation of Xbrane’s development focusing on the up-coming draft read-out from the phase III data for the biosimilarcandidate Xlucane and the planned application for market authorization.

Time: February 24, kl. 08.00 – 13.10  
Time and weblink to Xbrane´s presentation: kl 10.40,

The Småbolagsdagen is a collaboration between Financial Hearings and Börsveckan. The companies present their operations and afterwards follows a question-and-answer session led by Lars Frick, an analyst at Börsveckan.